Back

Validation of a novel direct method to determine reduced adherence to atorvastatin therapy

13 April 2023 (18:00 - 18:15)
Organised by:
Congress Presentation Part of: Young Investigators Award - Primary Care & Risk Factor Management Lipid-Lowering Agents EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Professor John Munkhaugen

Drammen Hospital, Drammen (Norway)

3 More presentations in this session

Presentation thumbnail
Effect of resistance training on HbA1c and other cardiovascular risk factors in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Mr M. Michielsen (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Left atrium volume is the predominant cardiac dimension related to new-onset atrial fibrillation in the general population
Mr Z. Lu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of traffic-related air pollution on the blood pressure response to exercise in individuals with hypertension
Mr H. Hung (Vancouver, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigators Award - Primary Care & Risk Factor Management
Video

The Event

Event poster

ESC Preventive Cardiology 2023

13 April 2023 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Statin adherence in primary care among patients with hypertension with and without other cardiometabolic diseases
thumbnail
Congress Session
Improving pharmacotherapy in primary prevention
thumbnail
Congress Session
Changing face of lipid-lowering therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources